Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-10-16

Clinical Trial Update: DIetary Supplements, Executive funcTions and Vitamin D (DIET-D) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial update investigating dietary supplements and Vitamin D for Mild Cognitive Impairment, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D (Cholecalciferol)

Snippet

Sponsor: University Hospital, Angers | Conditions: Mild Cognitive Impairment | Phase 2, Phase 3 | Status: UNKNOWN